The Tuberculosis Clinical Diagnostics Research Consortium (CDRC) will evaluate diagnostic tests and strategies in tuberculosis (TB) endemic countries. These efforts will be supported by clinicians familiar with the process for diagnosis or exclusion of TB. CDRC sites will serve diverse populations of patients, including HIV-positive and negative patients, pediatric patients, and patients with other co-infections and co-morbid conditions. The CDRC will also provide information to the greater community of TB investigators about TB diagnostic development.
Services are provided by the Tuberculosis Clinical Diagnostics Research Consortium (CDRC) at The Johns Hopkins University.
Last Updated March 05, 2014